Eurax
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- Eurax
- Generic name
- CROTAMITON
- Manufacturer
- Journey Medical Corporation
- Product type
- HUMAN PRESCRIPTION DRUG
- SPL set ID
- 99c826aa-c7dd-4e60-be9c-e9c151033d13
- SPL ID
- 4640ba32-cf20-18ad-e063-6394a90a4592
- Version
- 2
- Effective date
- 2025-12-17
- Source export date
- 2026-09-28
- Source partition
- 6
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0006-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-09-28/e0861bcde1444ef952820955caafc6f3fd29783e5ade07a13d933aa3336b399f/drug-label-0006-of-0014.json.zip
- Source manifest SHA-256
- cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
- Import run
- 20260929T050834Z
- Imported at
- 2026-09-29 05:38:31
| Harmonized routes |
|---|
| TOPICAL |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| application applno | NDA | 006927 | derived:openfda.application_number |
| application number | NDA006927 | openfda.application_number | |
| brand name | Eurax | openfda.brand_name | |
| generic name | CROTAMITON | openfda.generic_name | |
| manufacturer name | Journey Medical Corporation | openfda.manufacturer_name | |
| ndc | package | 69489-311-60 | openfda.package_ndc |
| ndc | product | 69489-311 | openfda.product_ndc |
| ndc11 | package | 69489031160 | derived:openfda.package_ndc |
| rxcui | 207864 | openfda.rxcui | |
| rxcui | 309552 | openfda.rxcui | |
| spl id | 4640ba32-cf20-18ad-e063-6394a90a4592 | id | |
| spl set id | 99c826aa-c7dd-4e60-be9c-e9c151033d13 | set_id | |
| unii | D6S4O4XD0H | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
WARNINGS Discontinue treatment with this product if severe irritation or sensitization develops, and institute appropriate therapy.
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions
ADVERSE REACTIONS Primary irritation reactions, such as dermatitis, pruritus, and rash, and allergic sensitivity reactions have been reported in a few patients.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.